Moreover, AFP remains the best marker to predict the recurrence and metastasis in AFP-positive HCC patients after operation [23],and recent studies showed that AFP have prognostic and predictive impact if determined prior to TACE [8]. The gene discussed is AFP; the disease is hepatocellular carcinoma.